BIRMF (Biorem) Other Stockholders Equity: $-0.00 Mil (As of Mar. 2026)


BIRMF Biorem Inc BIRMF
88 GF Score
Price $2.14
GF Value $1.94
Valuation Fairly Valued
View Full Analysis

What is Biorem Other Stockholders Equity?

Biorem BIRMF 88 Other Stockholders Equity is $-0.00 Mil as of Mar. 2026. GuruFocus rates BIRMF with a GF Score™ of 88/100 and a GF Value™ of $1.94 (Fairly Valued).

Biorem's Other Stockholders Equity for the quarter that ended in Mar. 2026 was $-0.00 Mil.

Biorem's quarterly Other Stockholders Equity increased from Sep. 2025 ($0.00 Mil) to Dec. 2025 ($0.00 Mil) but then declined from Dec. 2025 ($0.00 Mil) to Mar. 2026 ($-0.00 Mil).

Biorem's annual Other Stockholders Equity declined from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($0.00 Mil) but then increased from Dec. 2024 ($0.00 Mil) to Dec. 2025 ($0.00 Mil).

Biorem Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Biorem's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biorem Other Stockholders Equity Chart

Biorem Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.00 0.00 0.00 0.00 0.00

Biorem Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 -0.00 0.00 0.00 -0.00
BIRMF
88GF Score
Biorem Inc BIRMF
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biorem Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $-0.00 Mil mean?
Biorem (BIRMF) has a Other Stockholders Equity of $-0.00 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Biorem and its competitors.
Is Biorem's Other Stockholders Equity too high?
Biorem's current Other Stockholders Equity is $-0.00 Mil. Overall, Biorem has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Biorem's Other Stockholders Equity compare to VLTO and ZWS?
Biorem's Other Stockholders Equity of $-0.00 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for an Industrial Products company?
A good Other Stockholders Equity depends on the Industrial Products industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Biorem and its competitors. Biorem's current Other Stockholders Equity is $-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biorem stock overvalued right now?
Based on GuruFocus' analysis, Biorem (BIRMF) is currently considered Fairly Valued. The stock's GF Value™ is $1.94, compared to a current price of $2.14 — trading 10.3% above its estimated fair value. The current Other Stockholders Equity is $-0.00 Mil. Biorem's overall GF Score™ is 88/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Biorem (BIRMF), the current Other Stockholders Equity is $-0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biorem (BIRMF) Overvalued in 2026?

Based on GuruFocus' analysis, Biorem stock appears to be overvalued. The current stock price of $2.14 is trading 10.3% above its estimated GF Value™ of $1.94. GuruFocus considers Biorem to be Fairly Valued.

Key valuation signals for BIRMF:

  • Other Stockholders Equity: $-0.00 Mil
  • GF Value™: $1.94 vs. price of $2.14 (10.3% above fair value)
  • GF Score™: 88/100

No single metric tells the full story. See the BIRMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biorem Business Description

Other Exchanges R6D:GermanyBRM:Canada
Address 7496 Wellington Road 34, RR Number 3, Puslinch, Guelph, ON, CAN, N1H 6H9
Biorem Inc is an environmental biotechnology company. It is involved in the manufacturing of a comprehensive line of high efficiency air pollution control systems that are used to eliminate odorous and harmful contaminants. The company's products include Biofilters, Biogas Solutions, Multi-Stage Systems, Biotrickling filters, and services such as Media Sampling and Analysis, Biological processes and testing, Media replacements and Spare parts, and other related services. The company derives revenues from the sale of standard products, construction projects for specialized products, and services for repairs and maintenance. The group has a business presence in Canada, the United States, China and others, of which key revenue is derived from the United States.
88GF Score

Get the complete analysis for BIRMF

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.14
Price
$1.94
GF Value